1Celesia GG. Alzheimer' s disease: the proteoglycans hypothesis. Semin Thromb Hemost, 1991,17(suppl 2): 158.
2Ancsin JB. Amyloidogenesis : historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid, 2003,10(2):67.
3lozzo RV. Series Introduction: lteparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest,2001, 108(2): 165.
4Snow AD, Kinsella MG, Parks E, et al. Differential binding of vascular cell - derived proteoglycans ( perlecan, biglycan, decorin, and versican) to the beta -amyloid protein of Alzheimer's disease. Arch Biochem Biophys,1995, 320(1): 84.
5Verbeek MM, Otte HI, van-den-Born J, et al. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain Am J Pathol, 1999, 155(6): 2115.
6van Horssen J, Kleinnijenhuis J, Maass CN, et al. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging, 2002, 23(4): 537.
7van Horssen J, Wilhelmus MM, Heljasvaara R, et al. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.Brain Pathol, 2002, 12(4): 456.
8Cotman SL, Hairier W, Cole GJ. Agrin binds to betaamyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci, 2000, 15(2): 183.
9Castillo GM, Ngo C, Cummings J, et al. Perlecan binds to the betaamyloid proteins (A beta) of Alzbeimer' s disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurocbem 1997, 69(6): 2452.
10Schulz JG, Megow D, Reszka R, et al. Evidence that glypican is a receptor mediating beta-amyloid neurotoxicity in PC12 cells. Eur J Neurosci, 1998, 10(6): 2085.
3Christopher B C, Gerard L C, Theresa A G. Development of photocrosslinked sialic acid containing polymers for use in Aβ toxicity attenuation [ J ]. Biomaterials, 2008,29 : 3408-3414.
4Jack H, Johanneke K, Cathy N M, et al. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques[ J]. Neurobiol Aging, 2002, 23(4) :537-545.
5John H, Dennis J S. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics [ J ]. Science, 2002, 297(19) : 353-356.
6Nienke M T, lack H, Irene O H, et al. Amyloid β induces cellular relocalization and production of agrin and glypican-1 [ J]. Brain Res, 2009, 1260:38-46.
7Micha M M W, Robert M W W, Marcel M V. Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer' s disease [ J ]. Mol Neurobiol, 2007,35 : 203-216.
8Annika N A, Hinke A B M, John R C. Syndecans in wound healing, inflammation and vascular biology[ J]. Int J Biochem Cell Biol, 2007,39: 505-528.
9Ilona B B, Tom G, Toin H K, Guido D, et al. Sulphate moieties of heparan sulphate proteoglyeans associaued with senile plaques in Alzheimer's disease[J]. Alzheimer Dement,2008,4(4):T714-T715.
10Joel A C, Eliezer M, Edward R, et al. Heparan sulfate proteoglycan accumulation occurs concurrent with beta-amyloid protein plaque deposition in APP transgenic mouse models of Alzheimer' s disease [ J ]. Alzheimer Dement, 2006,2 (3) : S538.
